(ELA) Envela - Ratings and Ratios
Jewelry,Electronics,Recommerce
ELA EPS (Earnings per Share)
ELA Revenue
Description: ELA Envela
Envela Corp (NYSE MKT:ELA) is a US-based company operating in the Other Specialty Retail sub-industry. To understand its financial health, we examine the yearly Income Tax Expense. A key driver of a companys profitability, Income Tax Expense directly impacts Net Income. A decreasing Income Tax Expense can indicate improved profitability, while an increasing expense may signal reduced profitability.
With a Market Cap of $173.97M USD and a P/E ratio of 20.30, Envela Corps valuation is relatively moderate. The RoE of 15.75% suggests the company is generating substantial returns on equity, indicating effective use of shareholder capital. To further assess the companys performance, we can analyze key performance indicators (KPIs) such as Revenue Growth Rate, Gross Margin, and Operating Cash Flow Margin.
Key economic drivers for Envela Corp include consumer spending trends, competition in the specialty retail space, and overall market conditions. The companys ability to navigate these factors will significantly impact its future performance. By analyzing metrics such as Same-Store Sales Growth and Inventory Turnover, we can gain insights into the companys operational efficiency and its ability to adapt to changing market conditions.
To evaluate Envela Corps stock performance, we can examine its historical price movements and volatility. With a Beta of 0.219, the stock exhibits relatively low volatility compared to the broader market. The current price of $6.94 is near its 50-day and 200-day Simple Moving Averages (SMA), indicating a potential support level. Further analysis of the stocks momentum and relative strength can provide additional insights into its future price movements.
ELA Stock Overview
Market Cap in USD | 196m |
Sub-Industry | Other Specialty Retail |
IPO / Inception | 1992-03-19 |
ELA Stock Ratings
Growth Rating | 36.4% |
Fundamental | 66.9% |
Dividend Rating | 8.12% |
Return 12m vs S&P 500 | 17.7% |
Analyst Rating | 5.0 of 5 |
ELA Dividends
Currently no dividends paidELA Growth Ratios
Growth Correlation 3m | 72.2% |
Growth Correlation 12m | 25.3% |
Growth Correlation 5y | 41.6% |
CAGR 5y | 8.45% |
CAGR/Max DD 3y | 0.14 |
CAGR/Mean DD 3y | 0.34 |
Sharpe Ratio 12m | -0.09 |
Alpha | 0.14 |
Beta | 0.632 |
Volatility | 53.02% |
Current Volume | 31k |
Average Volume 20d | 43.5k |
Stop Loss | 7 (-5.7%) |
Signal | 0.29 |
Piotroski VR‑10 (Strict, 0-10) 6.5
Net Income (8.53m TTM) > 0 and > 6% of Revenue (6% = 11.9m TTM) |
FCFTA 0.09 (>2.0%) and ΔFCFTA 3.83pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
NWC/Revenue 22.29% (prev 26.18%; Δ -3.89pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
CFO/TA 0.13 (>3.0%) and CFO 10.9m > Net Income 8.53m (YES >=105%, WARN >=100%) |
Net Debt (-5.08m) to EBITDA (13.2m) ratio: -0.38 <= 3.0 (WARN <= 3.5) |
Current Ratio 4.58 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
Outstanding Shares last Quarter (26.0m) change vs 12m ago -1.03% (target <= -2.0% for YES) |
Gross Margin 23.68% (prev 25.39%; Δ -1.72pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
Asset Turnover 253.4% (prev 214.1%; Δ 39.25pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
Interest Coverage Ratio 26.65 (EBITDA TTM 13.2m / Interest Expense TTM 429.9k) >= 6 (WARN >= 3) |
Altman Z'' 6.30
(A) 0.53 = (Total Current Assets 56.6m - Total Current Liabilities 12.4m) / Total Assets 82.7m |
(B) 0.27 = Retained Earnings (Balance) 22.0m / Total Assets 82.7m |
(C) 0.15 = EBIT TTM 11.5m / Avg Total Assets 78.3m |
(D) 0.89 = Book Value of Equity 22.3m / Total Liabilities 24.9m |
Total Rating: 6.30 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 66.94
1. Piotroski 6.50pt = 1.50 |
2. FCF Yield 4.02% = 2.01 |
3. FCF Margin 3.80% = 0.95 |
4. Debt/Equity 0.26 = 2.47 |
5. Debt/Ebitda 1.13 = 1.59 |
6. ROIC - WACC 5.30% = 6.63 |
7. RoE 15.75% = 1.31 |
8. Rev. Trend 26.88% = 2.02 |
9. EPS Trend -30.64% = -1.53 |
What is the price of ELA shares?
Over the past week, the price has changed by -1.85%, over one month by +5.10%, over three months by +28.15% and over the past year by +39.74%.
Is Envela a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ELA is around 7.03 USD . This means that ELA is currently overvalued and has a potential downside of -5.26%.
Is ELA a buy, sell or hold?
- Strong Buy: 2
- Buy: 0
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the ELA price?
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 10 | 34.8% |
Analysts Target Price | 10 | 34.8% |
ValueRay Target Price | 7.8 | 4.9% |
Last update: 2025-09-04 04:36
ELA Fundamental Data Overview
CCE Cash And Equivalents = 22.9m USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 22.8182
P/S = 0.9857
P/B = 3.384
Beta = 0.219
Revenue TTM = 198.4m USD
EBIT TTM = 11.5m USD
EBITDA TTM = 13.2m USD
Long Term Debt = 9.67m USD (from longTermDebt, last quarter)
Short Term Debt = 5.19m USD (from shortTermDebt, last quarter)
Debt = 14.9m USD (Calculated: Short Term 5.19m + Long Term 9.67m)
Net Debt = -5.08m USD (from netDebt column, last quarter)
Enterprise Value = 187.5m USD (195.5m + Debt 14.9m - CCE 22.9m)
Interest Coverage Ratio = 26.65 (Ebit TTM 11.5m / Interest Expense TTM 429.9k)
FCF Yield = 4.02% (FCF TTM 7.53m / Enterprise Value 187.5m)
FCF Margin = 3.80% (FCF TTM 7.53m / Revenue TTM 198.4m)
Net Margin = 4.30% (Net Income TTM 8.53m / Revenue TTM 198.4m)
Gross Margin = 23.68% ((Revenue TTM 198.4m - Cost of Revenue TTM 151.4m) / Revenue TTM)
Tobins Q-Ratio = 8.41 (Enterprise Value 187.5m / Book Value Of Equity 22.3m)
Interest Expense / Debt = 0.71% (Interest Expense 106.2k / Debt 14.9m)
Taxrate = 22.77% (1.99m / 8.75m)
NOPAT = 8.85m (EBIT 11.5m * (1 - 22.77%))
Current Ratio = 4.58 (Total Current Assets 56.6m / Total Current Liabilities 12.4m)
Debt / Equity = 0.26 (Debt 14.9m / last Quarter total Stockholder Equity 57.8m)
Debt / EBITDA = 1.13 (Net Debt -5.08m / EBITDA 13.2m)
Debt / FCF = 1.97 (Debt 14.9m / FCF TTM 7.53m)
Total Stockholder Equity = 54.2m (last 4 quarters mean)
RoA = 10.31% (Net Income 8.53m, Total Assets 82.7m )
RoE = 15.75% (Net Income TTM 8.53m / Total Stockholder Equity 54.2m)
RoCE = 17.95% (Ebit 11.5m / (Equity 54.2m + L.T.Debt 9.67m))
RoIC = 13.09% (NOPAT 8.85m / Invested Capital 67.6m)
WACC = 7.79% (E(195.5m)/V(210.4m) * Re(8.34%)) + (D(14.9m)/V(210.4m) * Rd(0.71%) * (1-Tc(0.23)))
Shares Correlation 3-Years: -93.13 | Cagr: -0.33%
Discount Rate = 8.34% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 74.24% ; FCFE base≈6.08m ; Y1≈5.09m ; Y5≈3.79m
Fair Price DCF = 2.54 (DCF Value 65.9m / Shares Outstanding 26.0m; 5y FCF grow -19.66% → 3.0% )
EPS Correlation: -30.64 | EPS CAGR: -3.11% | SUE: 1.93 | # QB: True
Revenue Correlation: 26.88 | Revenue CAGR: 7.31%
Additional Sources for ELA Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle